Ads
related to: immunology
Search results
J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal
FierceBiotech· 23 hours agoNot satisfied with just one new immunology deal this month, Johnson & Johnson is plunking down $1.25...
Group Leader in Immunology - Paris, Ile-de-France (FR) job with INSERM DR IdF PARIS CENTRE |...
Nature· 23 hours agoThe Institut Necker Enfants Malades (INEM, https://www.institut-necker-enfants-malades.fr/) invites applications for a group leader position in Immunology. Although applicants ...
Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?
The Motley Fool via AOL· 1 hour agoImages. Eli Lilly's broad portfolio First, a bit of background on Lilly's earnings performance and...
The #1 Thing to Do If You're Having an Asthma Attack and Don't Have Your Inhaler, According to...
Parade via Yahoo News· 12 hours agoDuring an asthma attack, which can range from mild to severe, the muscles surrounding your bronchial...
Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal
WHTC 1450 Holland· 7 days ago(Reuters) - Biogen said on Wednesday it had agreed to buy privately held Human Immunology...
Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront
Market Watch· 7 days agoBiogen Inc. said Wednesday it’s acquiring privately held Human Immunology Biosciences for $1.15...
Turn Bio and HanAll to develop therapies for age-related conditions
Pharmaceutical Technology via Yahoo Finance· 1 hour agoThe company has since been closely monitoring Turn Bio's advancements, particularly the potential of...
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey...
Morningstar· 24 hours agoNumab Therapeutics AG (Numab), a clinical stage biotechnology company advancing a proprietary pipeline of immunology and oncology therapeutics, announced today that the Company ...
Biogen maintains stock target with Buy rating on acquisition intention By Investing.com
Investing.com· 7 days agoThe reaffirmation follows Biogen's announcement of its intention to acquire Human Immunology...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 minutes agoIGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, ...